BNZ Loan Facility Increase
www.aofrio.com
P: + 64 9 477 4500 E: info@aofrio.com
® is a registered Trademark of AoFrio Ltd
A: 78 Apollo Drive, Rosedale, Auckland 0632, New Zealand
PO Box: 302-533 North Harbour, Auckland 0751, New Zealand
17 April 2025
BNZ loan facility increase
AoFrio has accepted an offer from the BNZ of a $5 million increase to its trade finance facility to provide
working capital flexibility. The facility limit increases to $10 million. There is no change to interest rate
margins. Banking covenants remain the same except that they are required to be tested 6 monthly (at
half year and year end) instead of annually (at year end).
At 31 March 2025, cash at bank was $4.6 million and the BNZ trade finance facility was drawn to $3.9
million.
John Scott, Chair of AoFrio says, “The facility increase offer confirms the strong support AoFrio is
receiving from the BNZ, which is pleasing.”
ENDS
Contact
Greg Balla Howard Milliner
Chief Executive Officer Chief Financial Officer
Phone + 64 21 938 601 Phone +64 27 587 0455
AO227
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- OCA — Oceania Healthcare Limited: Oceania Refinance and Market Update2025-03-04
“2 Banking syndicate reaffirms support Successfully refinanced debt facilities. Sufficient headroom remains to execute the current development pipeline and provide forfuture growth. 1. Oceania accounting policy, finance costs on working capital facility and in relation to complete…”
- AFT — AFT Pharmaceuticals Limited: AFT sees strong FY 26 as revenue reaches new record2025-05-21
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2025 Previo…”
- APL — Asset Plus: Annual financial results2025-05-26
“NZX release Annual Financial Result 27 May 2025 • 35 Graham Street settlement occurred on 29 November 2024. • All external bank debt repaid immediately post the 35 Graham Street settlement. • A five cent per share (cash) special dividend was paid on 18 December 2024. • AF…”